Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Xencor on the deal. Xencor, a clinical-stage biopharmaceutical company and The University of Texas MD Anderson Cancer…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
